Paushak Intrinsic Value
PAUSHAKLTD • Chemicals
Current Stock Price
₹344.90
Primary Intrinsic Value
₹1034.70
Market Cap
₹103.5 Cr
+144.0%
Upside
Median Value
₹841.62
Value Range
₹587 - ₹1035
Assessment
Trading Below Calculated Value
Safety Margin
59.0%
PAUSHAKLTD Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1034.70 | ₹827.76 - ₹1241.64 | +200.0% | EPS: ₹100.60, Sector P/E: 12x |
| Book Value Method | asset | ₹862.25 | ₹776.02 - ₹948.48 | +150.0% | Book Value/Share: ₹1553.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹586.67 | ₹528.00 - ₹645.34 | +70.1% | Revenue/Share: ₹733.33, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹689.80 | ₹620.82 - ₹758.78 | +100.0% | EBITDA: ₹64.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹862.25 | ₹689.80 - ₹1034.70 | +150.0% | CF Growth: 6.1%, Discount: 15% |
| PEG Ratio Method | growth | ₹643.84 | ₹579.46 - ₹708.22 | +86.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹841.62 | ₹757.46 - ₹925.78 | +144.0% | Revenue Growth: 9.1%, Adj P/E: 8.4x |
| ROE Based Valuation | profitability | ₹689.80 | ₹620.82 - ₹758.78 | +100.0% | ROE: 7.7%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹1034.70 | ₹931.23 - ₹1138.17 | +200.0% | EPS: ₹100.60, BVPS: ₹1553.33 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
PAUSHAKLTD Intrinsic Value Analysis
What is the intrinsic value of PAUSHAKLTD?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Paushak (PAUSHAKLTD) is ₹841.62 (median value). With the current market price of ₹344.90, this represents a +144.0% variance from our estimated fair value.
The valuation range spans from ₹586.67 to ₹1034.70, indicating ₹586.67 - ₹1034.70.
Is PAUSHAKLTD undervalued or overvalued?
Based on our multi-method analysis, Paushak (PAUSHAKLTD) appears to be trading below calculated value by approximately 144.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.61 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 7.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 28.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.38x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Paushak
Additional stock information and data for PAUSHAKLTD
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹38 Cr | ₹10 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹56 Cr | ₹31 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹43 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹44 Cr | ₹23 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹30 Cr | ₹16 Cr | Positive Free Cash Flow | 8/10 |